BoneOscopy at a glance
BoneOscopy is a European Union’s Horizon EIC-Pathfinder Open project with the ambition to revolutionise the treatment landscape for bone cancer by establishing a new standard of care.
Bone metastasis remains a severe health challenge, with traditional imaging methods often falling short. BoneOscopy seeks to fill this gap by enabling daily tumour monitoring during treatment.
The project utilises spectroscopy analysis to assess bone density and calcium content without additional radiation exposure, providing precise treatment data for better decision-making.
This approach has the potential to herald a paradigm shift in the treatment of metastatic bone cancer, offering a more personalised therapeutic approach.
Hear from the coordinator
“BoneOscopy aims to develop a radically new technology to allow informed medical decisions by daily monitoring bone cancer during PRT.”
Prof. Joao Seco • BoneOscopy Project Coordinator
BoneOscopy aims to revolutionise bone metastasis analysis during particle beam treatments
Bone metastasis presents a significant health challenge, often inadequately addressed by traditional imaging methods. BoneOscopy aims to bridge this gap by enabling daily monitoring of tumors during treatment. Utilising spectroscopy analysis, BoneOscopy assesses bone density and calcium content without additional radiation exposure, delivering personalised and precise data that support informed treatment decisions. This innovative approach holds the potential to revolutionise metastatic bone cancer treatment, introducing a new era of precision and personalisation in therapy.
2-3 million deaths worldwide
5-10%
Newly diagnosed patients will eventually develop bone metastasis
Survival rates
1 year
10-50% patients
>5 years
<10% patients
Location of bone metastasis
